Equites Radar

GL · Globe Life Inc.

Insurance - LifeUnited StatesAnalyst view: Buy

$171.08

-7.02% last session

End-of-day data · updated 2026-07-25

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.91 from 11 analysts)
To mean target: +11.5%

Market cap

$13B

Enterprise value

$16B

Trailing P/E

11.5

Forward P/E

10.5

Dividend yield

1.0%

Beta

0.47

Avg volume

1M

Employees

4K

2D change

1.40%

5D change

-5.85%

10D change

-4.42%

30D change

-1.48%

60D change

10.88%

MTD change

-3.48%

YTD change

24.80%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.91
Covering analysts11
Mean price target$190.82
Low price target$150.00
Upside to mean target+11.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)40.4
50-day MA$167.50
200-day MA$146.72
Price vs 50-day MA+2.1%
Price vs 200-day MA+16.6%
MACD histogram-1.12
Volume vs 3-month avg3.0×
52w low $123.8152w high $184.76

Analyst sentiment over time — GL

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-24

Latest call per bank · past 12 months

JP Morgan

Overweight

$201

+17.5% vs price
▲ raised from $181Maintains · 2026-07-21

Jefferies

Hold

$166

-3.0% vs price
▲ raised from $147Maintains · 2026-07-10

Wells Fargo

Overweight

$193

+12.8% vs price
▲ raised from $172Maintains · 2026-07-09

Morgan Stanley

Overweight

$208

+21.6% vs price
▲ raised from $181Maintains · 2026-07-06

Recent rating actions

DateFirmActionRatingPrice target
2026-07-24Keefe, Bruyette & WoodsMaintainsOutperform$192 $190
2026-07-22TD CowenMaintainsBuy$215 $225
2026-07-21JP MorganMaintainsOverweight$181 $201
2026-07-15Piper SandlerMaintainsOverweight$175 $200
2026-07-13Evercore ISI GroupMaintainsIn-Line$157 $176
2026-07-13Keefe, Bruyette & WoodsMaintainsOutperform$180 $192
2026-07-10JefferiesMaintainsHold$147 $166
2026-07-09Wells FargoMaintainsOverweight$172 $193

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-23

  • RSI (14): RSI is 40 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 2.1% above the 50-day MA ($167.50).
  • Price vs 200-day MA: Trading 16.6% above the 200-day MA ($146.72).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-1.12) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($123.81) and high ($184.76).

GL Price Chart

Loading chart for GL

Fundamentals

Revenue (TTM)$6.0B
EBITDA$2.0B
Free cash flow
Operating cash flow
Book value / share$78.12
Net debt / EBITDA1.7
WACC7.0%
Revenue growth8.00%
Earnings growth20.00%

About Globe Life Inc.

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

More in Insurance - Life

Screen GL against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.